GUJARAT THEMIS BIOSYN
Back to Income Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹151 Cr | ₹170 Cr | ₹148 Cr | ₹115 Cr | ₹91 Cr |
What is the latest Revenue of GUJARAT THEMIS BIOSYN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹148 Cr |
| Mar2022 | ₹115 Cr |
| Mar2021 | ₹91 Cr |
How is Revenue of GUJARAT THEMIS BIOSYN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | -11.20 | |
| Mar2024 | ₹170 Cr | 14.45 | |
| Mar2023 | ₹148 Cr | 29.19 | |
| Mar2022 | ₹115 Cr | 26.82 | |
| Mar2021 | ₹91 Cr | - | |
Compare Revenue of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹5,361.0 Cr | -2.6% | 14.1% | 10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -2.6% |
14.1% |
10.6% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses